These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 9427770)

  • 1. Effects of lithium gammalinolenate on the perfusion of liver and pancreatic tissues in pancreatic cancer.
    Kairemo KJ; Jekunen AP; Korppi-Tommola ET; Pyrhönen SO
    Anticancer Res; 1997; 17(5B):3729-36. PubMed ID: 9427770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An open-label phase I/II dose escalation study of the treatment of pancreatic cancer using lithium gammalinolenate.
    Fearon KC; Falconer JS; Ross JA; Carter DC; Hunter JO; Reynolds PD; Tuffnell Q
    Anticancer Res; 1996; 16(2):867-74. PubMed ID: 8687143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue distribution and metabolism of gamma-linolenoyl-3-eicosapentaenoyl propane diol enterally or intravenously administered to mice bearing human pancreatic carcinomas.
    De Antueno R; Bai M; Elliot M
    Anticancer Res; 1999; 19(3A):2041-8. PubMed ID: 10470146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiolabeled neurotensin analog, 99mTc-NT-XI, evaluated in ductal pancreatic adenocarcinoma patients.
    Buchegger F; Bonvin F; Kosinski M; Schaffland AO; Prior J; Reubi JC; Bläuenstein P; Tourwé D; García Garayoa E; Bischof Delaloye A
    J Nucl Med; 2003 Oct; 44(10):1649-54. PubMed ID: 14530481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of lithium gamma-linolenate therapy of pancreatic cancer on perfusion in liver and pancreatic tissues.
    Kairemo KJ; Jekunen AP; Korppi-Tommola ET; Pyrhönen SO
    Pancreas; 1998 Jan; 16(1):105-6. PubMed ID: 9436871
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of lithium gamma-linolenate on the growth of experimental human pancreatic carcinoma.
    Ravichandran D; Cooper A; Johnson CD
    Br J Surg; 1998 Sep; 85(9):1201-5. PubMed ID: 9752859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
    Lind P; Gallowitsch HJ
    Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo and in vitro biotransformation of the lithium salt of gamma-linolenic acid by three human carcinomas.
    de Antueno R; Elliot M; Ells G; Quiroga P; Jenkins K; Horrobin D
    Br J Cancer; 1997; 75(12):1812-8. PubMed ID: 9192987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
    Wang C
    Acta Radiol Suppl; 1998; 415():1-31. PubMed ID: 9571956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis.
    Menendez JA; Ropero S; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Jun; 24(6):1369-83. PubMed ID: 15138577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic effects of gamma-linolenic acid-alpha-lipoic acid conjugate in streptozotocin diabetic rats.
    Khamaisi M; Rudich A; Beeri I; Pessler D; Friger M; Gavrilov V; Tritschler H; Bashan N
    Antioxid Redox Signal; 1999; 1(4):523-35. PubMed ID: 11233149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic effects of two gamma linoleic salts (lithium gammalinolenate or meglumine gammalinolenate) alone or associated with a nitrosourea: an experimental study on human glioblastoma cell lines.
    Ilc K; Ferrero JM; Fischel JL; Formento P; Bryce R; Etienne MC; Milano G
    Anticancer Drugs; 1999 Apr; 10(4):413-7. PubMed ID: 10378677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An aqueous formulation of gamma-linolenic acid with anti-proliferative action on human pancreatic cancer cell lines.
    Agombar A; Cooper AJ; Johnson CD
    Anticancer Drugs; 2004 Feb; 15(2):157-60. PubMed ID: 15075672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporary redistribution of hepatic or pancreatic blood flow by vascular occluders during intra-arterial chemotherapy for carcinoma of the liver or pancreas.
    Shimamura Y; Gunvén P; Ishii M; Abe K
    Surg Gynecol Obstet; 1993 Dec; 177(6):617-9. PubMed ID: 8266275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal assessment of pancreatic blood flow and perfusion following secretin stimulation using noninvasive MRI.
    Cox EF; Smith JK; Chowdhury AH; Lobo DN; Francis ST; Simpson J
    J Magn Reson Imaging; 2015 Nov; 42(5):1233-40. PubMed ID: 25787269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors using technetium-99m-MIBI scintigraphy.
    Taki J; Sumiya H; Asada N; Ueda Y; Tsuchiya H; Tonami N
    J Nucl Med; 1998 Jul; 39(7):1179-84. PubMed ID: 9669390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of 99mTc-1-thioglucose in rats: effect of administration route on pancreatic specificity.
    Risch VR; Honda T; Heindel ND; Emrich JL; Brady LW
    Radiology; 1977 Sep; 124(3):837-8. PubMed ID: 887787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial technetium-99m-tetrofosmin and technetium-99m-sestamibi kinetics in normal subjects and patients with coronary artery disease.
    Münch G; Neverve J; Matsunari I; Schröter G; Schwaiger M
    J Nucl Med; 1997 Mar; 38(3):428-32. PubMed ID: 9074532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.